Revolution Medicines Stock

revolutionmedicines.comHealthcare / BioTech & PharmaFounded: 2014Funding to Date: $226MM

REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients.

Register To Buy and Sell Shares

For more details on financing and valuation for Revolution Medicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Revolution Medicines’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Revolution Medicines.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Mark Goldsmith Ph.D
President, Chief Executive Officer and Board Member
Martin Burke MD
Scientific Advisory Board Chairman & Co-Founder
Kevan Shokat Ph.D
Co-Founder & Chief Advisory Board Member
Steve Kelsey MD
President, Research & Development
Margaret Horn JD
Chief Operating Officer
Michael Fischbach Ph.D
Co-Founder & Scientific Advisory Board Member

Board Members

Alexis Borisy
Third Rock Ventures
Kevan Shokat Ph.D
Michael Fischbach Ph.D
Barbara Weber MD
Third Rock Ventures
Martin Burke MD
Vincent Miller MD
Elizabeth Anderson
Laurence Lasky Ph.D
The Column Group
Thilo Schroeder Ph.D
Nextech Invest

Frequently Asked Questions About Revolution Medicines’ Stock

plusminus
Can you buy Revolution Medicines’ stock?
Revolution Medicines is not publicly traded on NYSE or NASDAQ in the U.S. To buy Revolution Medicines’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Revolution Medicines’ stock?
Yes, you can sell stock of a private company like Revolution Medicines. Forge can help you sell your Revolution Medicines stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Revolution Medicines’ stock price?
Revolution Medicines is a privately held company and therefore does not have a public stock price. However, you may access Revolution Medicines’ private market stock price with Forge Data.
plusminus
What is Revolution Medicines’ stock ticker symbol?
Revolution Medicines does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Revolution Medicines Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its initial public...
Xconomy: Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
The RAS family of proteins is one of the hottest targets in cancer research despite being one of the hardest for drug hunters to hit. Revolution Medicines
Revolution Medicines Closes $100M Financing | FinSMEs
Revolution Medicines, Inc., a Redwood City, Calif.-based clinical-stage leader in the discovery and development of novel small molecule inhibitors of frontier oncology targets within notorious pathways, closed a $100m Series C equity financing
Updated on: Feb 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.